These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 2654665

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pharmacokinetics of cis-diammine-1,1-cyclobutane dicarboxylate platinum(II) in patients with normal and impaired renal function.
    Harland SJ, Newell DR, Siddik ZH, Chadwick R, Calvert AH, Harrap KR.
    Cancer Res; 1984 Apr; 44(4):1693-7. PubMed ID: 6367971
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Some effects of combination chemotherapy with cis-platinum on renal function in patients with nonseminomatous testicular carcinoma.
    Meijer S, Sleijfer DT, Mulder NH, Sluiter WJ, Marrink J, Koops HS, Brouwers TM, Oldhoff J, van der Hem GK, Mandema E.
    Cancer; 1983 Jun 01; 51(11):2035-40. PubMed ID: 6340821
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Nephrotoxicity and myelotoxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in rats].
    Horn U, Härtl A, Neuhaus G, Stöckel U, Schröer HP, Hoffmann H.
    Arch Geschwulstforsch; 1989 Jun 01; 59(4):245-50. PubMed ID: 2802932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Preclinical studies identifying carboplatin as a viable cisplatin alternative.
    Harrap KR.
    Cancer Treat Rev; 1985 Sep 01; 12 Suppl A():21-33. PubMed ID: 3910219
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Ototoxicity of cisplatin vs. platinum analogs CBDCA (JM-8) and CHIP (JM-9).
    Schweitzer VG, Rarey KE, Dolan DF, Abrams G, Litterst CJ, Sheridan C.
    Otolaryngol Head Neck Surg; 1986 Apr 01; 94(4):458-70. PubMed ID: 3086808
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. A comparison of the effects of tetraplatin and cisplatin on renal function and gentamicin pharmacology in rats.
    Engineer MS, Brown NS, Ho DH, Newman RA, Bulger RE.
    Toxicology; 1989 Dec 01; 59(2):151-62. PubMed ID: 2588264
    [Abstract] [Full Text] [Related]

  • 15. [Acute and subacute toxicity of antineoplastic Pt(II) and Pt(IV) coordination compounds in laboratory rodents].
    Härtl A, Güttner J, Horn U, Jelinek F, Stöckel U, Schröer HP, Hoffmann H.
    Arch Geschwulstforsch; 1989 Dec 01; 59(4):239-44. PubMed ID: 2640563
    [Abstract] [Full Text] [Related]

  • 16. The comparative pharmacokinetics of carboplatin and cisplatin in mice and rats.
    Siddik ZH, Newell DR, Boxall FE, Harrap KR.
    Biochem Pharmacol; 1987 Jun 15; 36(12):1925-32. PubMed ID: 3297068
    [Abstract] [Full Text] [Related]

  • 17. The influence of platinum drugs on the radiation response of rat kidneys.
    van Rongen E, Kuijpers WC, Baten-Wittwer A.
    Radiother Oncol; 1994 May 15; 31(2):138-50. PubMed ID: 8066193
    [Abstract] [Full Text] [Related]

  • 18. Acute and cumulative effects of carboplatin on renal function.
    Sleijfer DT, Smit EF, Meijer S, Mulder NH, Postmus PE.
    Br J Cancer; 1989 Jul 15; 60(1):116-20. PubMed ID: 2679841
    [Abstract] [Full Text] [Related]

  • 19. Antitumor effects of three platinum complexes, (-)-(R)-2-aminomethylpyrrolidine(1,1-cyclobutanedicarboxylato)-platinum (II) monohydrate (DWA2114R), cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) (CBDCA) and cis-diamminedichloroplatinum(II) (CDDP), in mice.
    Endo K, Akamatsu K, Matsumoto T, Morikawa K, Koizumi M, Mitsui H, Koizumi K.
    Anticancer Res; 1992 Jul 15; 12(1):49-58. PubMed ID: 1567181
    [Abstract] [Full Text] [Related]

  • 20. Blood clearance of radioactively labelled cis-diammine 1,1-cyclobutane dicarboxylate platinum (II) (CBDCA) in cancer patients.
    Sharma H, Thatcher N, Baer J, Zaki A, Smith A, McAucliffe CA, Crowther D, Owens S, Fox BW.
    Cancer Chemother Pharmacol; 1983 Jul 15; 11(1):5-7. PubMed ID: 6349844
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.